The respiratory disposable market would grow at a CAGR of 12.93% over the predicted time frame. The market is expected to increase in value from US$ 1.73 Bn in 2022 to US$ 4.57 Bn in 2030.
The on respiratory disposable Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2013
Report Scope of the Respiratory Disposable Market
| Report Coverage | Details |
| Market Size in 2022 | USD 1.73 Billion |
| Market Size by 2030 | USD 4.57 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 12.93% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Patient Group, End User, Application, Geography |
| Companies Mentioned | Fisher and Paykel Healthcare, Smith Group (Smith Medical Inc.), Hamilton Medical AG, Getinge AB, Invacare Corporation, Masimo Corporation, Medtronic Plc., Dragerwerk AG and CO. KGAA, Air liquid S.A, Chart Industries |
A recent report provides crucial insights along with application based and forecast information in the Global Respiratory disposable Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Respiratory disposable market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Respiratory disposable market are included as given below:
Respiratory disposable Market Key Players
- Fisher and Paykel Healthcare
- Smith Group (Smith Medical Inc.)
- Hamilton Medical AG
- Getinge AB
- Invacare Corporation
- Masimo Corporation
- Medtronic Plc.
- Dragerwerk AG and CO. KGAA
- Air liquid S.A
- Chart Industries
Market Segments
By Product
- Laryngoscope
- Tubes
- Breathing Bag
- Masks
- Resuscitator
- Others
By Patient Group
- Neonatal & Pediatric
- Adult
- Geriatric
By End User
- Hospitals, Nursing Homes, & Clinics
- Trauma Centers
- Homecare
By Application
- Pharmaceuticals
- Food & beverages
- Cosmetics
- Automobiles
- Metals
- Chemical Companies
- Health Sectors
- Power generation
- Oil and gases and other
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global respiratory disposable market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the respiratory disposable market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Respiratory Disposable Market
5.1. COVID-19 Landscape: Respiratory Disposable Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Respiratory Disposable Market, By Product
8.1. Respiratory Disposable Market, by Product, 2022-2030
8.1.1. Laryngoscope
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Tubes
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Breathing Bag
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Masks
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Resuscitator
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Respiratory Disposable Market, By Patient Group
9.1. Respiratory Disposable Market, by Patient Group e, 2022-2030
9.1.1. Neonatal & Pediatric
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Adult
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Geriatric
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Respiratory Disposable Market, By End User
10.1. Respiratory Disposable Market, by End User, 2022-2030
10.1.1. Hospitals, Nursing Homes, & Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Trauma Centers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Homecare
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Respiratory Disposable Market, By Application
11.1. Respiratory Disposable Market, by Application, 2022-2030
11.1.1. Pharmaceuticals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceuticals
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Cosmetics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Automobiles
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Metals
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Chemical Companies
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Health Sectors
11.1.7.1. Market Revenue and Forecast (2017-2030)
11.1.8. Power generation
11.1.8.1. Market Revenue and Forecast (2017-2030)
11.1.9. Oil and gases and other
11.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Respiratory Disposable Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.1.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
Chapter 13. Company Profiles
13.1. Fisher and Paykel Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Smith Group (Smith Medical Inc.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hamilton Medical AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Getinge AB
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Invacare Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Masimo Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Medtronic Plc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dragerwerk AG and CO. KGAA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Air liquid S.A
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Chart Industries
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments